Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03189836
Title Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Unum Therapeutics Inc.

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

primary mediastinal B-cell lymphoma


ACTR707 + Rituximab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.